Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster
ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster
ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster
Submitted by
admin
on August 29, 2017 - 11:05am
Source:
Fierce Pharma
News Tags:
Novartis
Ilaris
Headline:
ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster
Do Not Allow Advertisers to Use My Personal information
